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This study reports the isolation and biochemical characterization of two different serine proteases from
Bothrops pirajai snake venom, thus providing a comparative analysis of the enzymes. The isolation
process consisted of three consecutive chromatographic steps (Sephacryl S-200, Benzamidine Sepharose
and C2/C18), resulting in two serine proteases, named BpirSP27 and BpirSP41 after their molecular
masses by mass spectrometry (27,121 and 40,639 Da, respectively). Estimation by SDS-PAGE under
denaturing conditions showed that, when deglycosylated with PNGase F, BpirSP27 and BpirSP41 had
their molecular masses reduced by approximately 15 and 42%, respectively. Both are acidic enzymes,
with pI of approximately 4.7 for BpirSP27 and 3.7 for BpirSP41, and their N-terminal amino acid
sequences showed 57% identity to each other, with high similarity to the sequences of other snake venom
serine proteases (SVSPs). The enzymes showed different actions on bovine ﬁbrinogen, with BpirSP27
acting preferentially on the Bb chain and BpirSP41 on both Aa and Bb chains. The two serine proteases
were also able to degrade ﬁbrin and blood clots in vitro depending on the doses and incubation periods,
with higher results for BpirSP41. Both enzymes coagulated the human plasma in a dose-dependent
manner, and BpirSP41 showed a higher coagulant potential, with minimum coagulant dose (MCD) of
w3.5 mg versus 20 mg for BpirSP27. The enzymes were capable of hydrolyzing different chromogenic
substrates, including S-2238 for thrombin-like enzymes, but only BpirSP27 acted on the substrate S-2251
for plasmin. They also showed high stability against variations of temperature and pH, but their activities
were signiﬁcantly reduced after preincubation with Cu2þ ion and speciﬁc serine protease inhibitors. In
addition, BpirSP27 induced aggregation of washed platelets to a greater extent than BpirSP41. The results
showed signiﬁcant structural and functional differences between B. pirajai serine proteases, providing
interesting insights into the structureefunction relationship of SVSPs.
 2012 Elsevier Masson SAS. Open access under the Elsevier OA license.1. Introduction
Snake venoms are complexmixtures of numerous inorganic and
organic components predominantly constituted by peptides and
proteins, including enzymes such as phospholipases A2, L-amino
acid oxidases, metalloproteases and serine proteases [1,2]. The
composition of snake venoms depends on several factors, such as
genetics, age, sex, diet and geographic location of the specimen,
leading to an efﬁcient product of complex nature that promotes
immobilization, death and initial digestion of prey [3,4]. Bothropsx: þ55 16 36024725.
L. Menaldo), suvilela@usp.br
nder the Elsevier OA license.envenomation causes various pathophysiological disorders,
including systemic alterations of hemostasis associated with the
activation of prothrombin and factor X, ﬁbrinogen consumption
and platelet aggregation, resulting in characteristic systemic
symptoms [5].
Snake venoms contain a variety of proteins that affect hemo-
stasis, some by interaction with factors of the coagulation cascade,
others by action on platelets and other components of the hemo-
static system. Several of these proteins are enzymes, such as
nucleotidases, phospholipases A2, metalloproteases and serine
proteases, while others, like C-type lectins and disintegrins, show
no enzymatic activity [1,6].
Serine proteases present several functions and may be involved
in digestion, activation of the complement system, cell
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plants and various animals [6]. These enzymes possess a highly
conserved catalytic triad formed by residues His57, Asp102 and
Ser195, and they affect various steps of the coagulation
cascade, often not speciﬁcally through proteolytic degradation, but
by selectively activating or inactivating coagulation factors involved
in platelet aggregation, coagulation and ﬁbrinolysis [6,7]. Individ-
ually, serine proteases are not considered lethal, but they
contribute to the toxic effect when combined with other proteins of
the venom [6].
According to their effects on the hemostatic system, serine
proteases can be classiﬁed as kallikrein-like enzymes, which lower
the blood pressure by releasing bradykinin, or thrombin-like
enzymes, which resemble the activity of thrombin on ﬁbrinogen
and form ﬁbrin by cleavage of the Aa and/or Bb chains, releasing
ﬁbrinopeptides A and/or B [6,7]. The ﬁbrin monomers generated by
these enzymes suffer limited polymerization, since usually only
one ﬁbrinopeptide is cleaved and there is no activation of factor
XIII, which in its activated form (XIIIa) catalyzes the union of the
monomers and consolidates the clot formation [6].
Various studies already described the isolation and character-
ization of many snake venom serine proteases (SVSPs), including
several from different Bothrops species, but this class of enzymes
had not yet been explored for Bothrops pirajai snake venom up to
the present work. This snake species was ﬁrst described by Amaral
[8], and is an endemic species of the state of Bahia, northeastern
Brazil, where it is popularly known as “jararacuçu da Bahia”.
Currently, this species is included in the “National List of the Bra-
zilian Fauna Species Threatenedwith Extinction” in the category EN
(endangered), according to the Brazilian Ministry of Environment,
and in the list of “The International Union for Conservation of
Nature” (IUCN) in the category VU (vulnerable) [9].
The medical-scientiﬁc interest in thrombin-like enzymes has
grown considerably due to speciﬁc differences when compared to
thrombin, which is a multifunctional enzyme [10]. These serine
proteases are promising in clinical medicine as deﬁbrinogenating
agents, which could be used in patients suffering from thrombosis,
cerebral and myocardial infarction, peripheral vascular disease and
acute ischemia [11e13]. Additionally, some SVSPs have been used in
the preparation of ﬁbrin sealants, which are very effective surgical
adhesive products used in different medical conditions [14,15].
In this context, this study presents data on the isolation, char-
acterization and comparative analysis of two distinct thrombin-like
serine proteases from B. pirajai snake venom, which belong to
a class of enzymes with great medical and scientiﬁc potential.
2. Materials and methods
2.1. Materials
The venom of B. pirajai was acquired from the serpentarium
Bioagents Bioactive Proteins Ltd. (Batatais-SP, Brazil). The chro-
matographic resins and reagents for biochemical and enzymatic
assayswere obtained fromGEHealthcare, Merck or SigmaeAldrich.
The p-nitroanilide substrates S-2238, S-2222, S-2302, S-2266 and
S-2251 were obtained from Chromogenix. Materials and equip-
ment used were described throughout the methodology and
reagents not speciﬁed were of analytical grade.
2.2. Human plasma
Human plasma was obtained from the blood of healthy volun-
teers of both sexes, aged 20e40 years, which did not receive
medication for ten days prior to the experiments. The donor blood
was collected by venipuncture using 3.8% sodium citrate (9:1, v/v)as anticoagulant and then centrifuged at 1500 g for 15 min and
room temperature. All procedures involving humans were
approved by the Research Ethics Committee of FCFRP-USP (CEP/
FCFRP n. 123/2011).
2.3. Isolation of B. pirajai serine proteases
Chromatographic fractionation of B. pirajai snake venom to
obtain the enzymes of interest was initiated bymolecular exclusion
on Sephacryl S-200, followed by afﬁnity chromatography on Ben-
zamidine Sepharose 6B and ﬁnally by reversed-phase high perfor-
mance liquid chromatography (RP-HPLC) using a mRPC C2/C18 ST
4.6/100 column. All chromatographic fractions were monitored by
their absorbance at 280 nm using a spectrophotometer Thermo
Scientiﬁc GENESYS 10UV or program UNICORN 5.11 (GE Health-
care) for the AKTA puriﬁer system. Data were then plotted on
graphs using the program Origin 8.
Initially, B. pirajai crystallized crude venom (350 mg) was sus-
pended in 5 mL of 0.05 M TriseHCl pH 7.6, followed by centrifu-
gation at 10,000 g for 10 min and room temperature. The clear
supernatant obtained was applied to a chromatography column
containing Sephacryl S-200 resin (110  2.5 cm), equilibrated and
eluted with 0.05 M TriseHCl pH 7.6. Fractions of 3 mL/tube were
collected at a ﬂow of 30 mL/h and room temperature. The fraction
that showed coagulant activity (S1b) was concentrated in an
Amicon ultraﬁltration system (Millipore) using an Ultracel YM-10
membrane and applied to the next chromatographic step.
For the second chromatography, a column containing Benza-
midine Sepharose 6B resin (8.5  2.5 cm) was used. The elution of
fractions was performed using three different buffers: 0.05 M
TriseHCl pH 7.6 (buffer 1, also used to equilibrate the column);
0.05 M TriseHCl pH 7.6 þ 0.5 M NaCl (buffer 2) and ﬁnally, 0.02 M
glycine-HCl pH 3.2 (buffer 3). Fractions of 3 mL/tube were collected
at a ﬂow of 30 mL/h and room temperature. The acidic pH of buffer
3 was neutralized by adding 400 mL of 1.0 M Tris pH 9.0 to each
collected tube. The coagulant fraction (B3) of this chromatographic
step was concentrated and desalted as previously mentioned, and
then lyophilized.
Afterward, a C2/C18 reversed-phase column was used in an
AKTA puriﬁer system (GE Healthcare), with solvents A (0.1% tri-
ﬂuoroacetic acid e TFA) and B (50% acetonitrile and 0.1% TFA).
Lyophilized fraction B3 was dissolved in solvent A and applied to
the system using a loop of 500 mL. The elution was performed at
a ﬂow rate of 0.5 mL/minwith a segmented concentration gradient
of 0e60% solvent B (5 column volumes) and 60e100% solvent B (20
column volumes).
2.4. Polyacrylamide gel electrophoresis in the presence of sodium
dodecyl sulfate (SDS-PAGE)
SDS-PAGE of chromatographic fractions and puriﬁed enzymes
was performed under denaturing conditions using a 12% poly-
acrylamide gel and samples in the presence of SDS and b-mer-
captoethanol, according to Laemmli [16].
2.5. Molecular mass determination
Themolecular masses of both serine proteases were determined
by SDS-PAGE and by matrix assisted laser desorption ionization e
time of ﬂightemass spectrometry (MALDI-TOF MS). SDS-PAGE: the
estimation was made by the interpolation of a linear logarithmic
curve of relative molecular mass of standard proteins (SDS7 from
SigmaeAldrich or Spectra Multicolor Broad Range Protein Ladder
from Fermentas Life Sciences) versus the distance of migration in
the gel. MALDI-TOF MS: analyses were performed using an AXIMA
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Biotech) andmass spectra were acquired in linear mode, previously
calibrated with bovine serum albumin (BSA), insulin, cytochrome c,
ribonuclease, apomyoglobin and aldolase. The molecular mass
range evaluated was from 3000 to 100,000 m/z. The samples were
diluted in 50 mL of Milli-Q water, mixed in a 1:1 ratio with a matrix
consisting of sinapinic acid (10 mg/mL) in 50% acetonitrile and 0.1%
TFA, and applied on the MALDI plate using the dried-droplet
method.
2.6. Deglycosylation assays
The deglycosylation enzymes N-glycosidase F (PNGase F) and
neuraminidase were used according to the manufacturer’s
instructions (New England BioLabs) to assess the glycosylation
degree of the serine proteases. For the tests with PNGase F, each
puriﬁed enzyme (40 mg) was denatured by heating at 100 C for
10min in the presence of denaturing buffer (5% SDS and 0.4MDTT).
Afterward, reaction buffer (0.5 M sodium phosphate pH 7.5), 10%
NP40 solution (used to neutralize the SDS present in the denaturing
buffer) and PNGase F (200 U) were added to the samples,
completing the volume to 40 mL with Milli-Q water. Similarly, for
the treatment with neuraminidase, each serine protease
(40 mg) was denatured and then, reaction buffer (50 mM sodium
citrate pH 6.0) and neuraminidase (150 U) were added along
with Milli-Q water to a ﬁnal volume of 40 mL. After incubation at
37 C for 24 h, the reaction solutions were analyzed by 12% SDS-
PAGE [16].
2.7. Isoelectric focusing
The isoelectric focusing of the serine proteases was performed
according to the method described by Vesterberg [17], with minor
modiﬁcations [18].
2.8. N-Terminal sequencing and multiple alignments
The N-terminal amino acid sequences of the serine proteases
were obtained by protein sequencing according to the method of
Edman degradation [19]. The sequences were then compared by
multiple alignments using the program ClustalX version 2.0.11
(http://www.clustal.org/). For comparative purposes, N-terminal
sequences of other snake venom serine proteases were located
using the “protein BLAST” tool fromNCBI (http://blast.ncbi.nlm.nih.
gov/).
2.9. Esterase activity
The esterase activity of the enzymes was determined using the
substrate Na-p-tosyl-L-arginine methyl ester (TAME), according to
methodology of Hummel [20] with modiﬁcations. The activity was
assessed by the absorbance at 247 nm after 30 min of reaction of
the enzymes (5 mg) with 1 mM TAME (ﬁnal concentration) at 37 C.
The reaction mixtures consisted of 2.5 mL of solution of 0.02 M
TriseHCl and 0.15 M KCl pH 8.1, 0.3 mL of 0.01 M TAME, and 0.2 mL
of solution containing the enzymes (5 mg in Milli-Q water). One
TAME unit represents an increase of 0.01 absorbance units resulting
from the hydrolytic activity of the enzymes on the substrate. The
results were expressed as speciﬁc activity, related toTAME units per
milligram of protein (U/mg).
In order to evaluate the stability of the serine proteases, the
enzymes were preincubated for 30 min at different temperatures
(4, 25, 37, 45, 60 and 100 C) and pH buffers (3.0, 4.5, 6.0, 7.5, 9.0 and
10.5) at 37 C, and their activities were then tested on TAME. The
activity of the enzymes was also evaluated after preincubation for30 min at 37 C in the presence of different inhibitors at 1 mM
(phenylmethylsulfonyl ﬂuoride e PMSF, benzamidine, leupeptin,
aprotinin, b-mercaptoethanol, dithiothreitol e DTT, ethyl-
enediaminetetraacetic acid e EDTA, ethylene glycol tetraacetic acid
e EGTA and 1,10-phenanthroline).
2.10. Fibrinogenolytic activity
The ﬁbrinogenolytic activity of the serine proteases was deter-
mined by SDS-PAGE according to methodology of Edgar and
Prentice [21] with modiﬁcations [22]. The inhibition of this
activity was evaluated after preincubation of the enzymes with
speciﬁc inhibitors (5 mM PMSF and 5 mM benzamidine) for 30 min
at 37 C.
2.11. Fibrinolytic activity
The ﬁbrinolytic activity of the enzymes was evaluated using
ﬁbrin plates, according to the method described by Leitão and
coworkers [23]. The analysis was done visually and quantiﬁed by
the halos of lysis produced after 24e48 h of incubation at 37 C,
comparing with a positive (B. pirajai crude venom) and a negative
control (phosphate buffered saline e PBS).
2.12. Procoagulant activity
The chromogenic substrates S-2238 (for thrombin-like
enzymes), S-2222 (for factor Xa), S-2266 (for glandular kallikrein
and factor XIa), S-2302 (for plasma kallikrein, factor XIa and XIIa)
and S-2251 (for plasmin) were used to assess the procoagulant
activity of the serine proteases. The hydrolysis of the substrates
(0.4 mM, ﬁnal concentration) by different concentrations of the
enzymes was determined by monitoring the reaction (ﬁnal volume
of 100 mL) at 405 nm in a Powerwave XS2 microreader (Biotek) for
10 min at 37 C. Then, the blank absorbance of each chromogenic
substrate was subtracted from the absorbance values obtained for
the reactions with the serine proteases.
The substrate S-2238 was also used to determine the effects of
inhibitors and metal cations on the activity of the serine proteases.
For this, the enzymes (20 mg/mL) were preincubated with 5 mM
PMSF, benzamidine or EDTA and divalent cations at 10 mM (Ca2þ,
Ba2þ, Mn2þ and Cu2þ) for 30 min at 37 C and the reactionwas then
initiated with the addition of S-2238.
2.13. Coagulant activity
The minimum coagulant dose (MCD) of the serine proteases,
considered as the amount of enzyme capable of coagulating the
plasma in 60 s [24], was determined using 150 mL of citrated human
plasma at 37 C and different doses of the enzymes (1e20 mg
diluted in 50 mL of Milli-Q water). The clotting time, measured in
seconds, was characterized visually by the appearance of ﬁbrin
networks or immediate formation of a clot.
The coagulant activity determined by kinetic assay was per-
formed in a Powerwave XS2 microreader (Biotek) using 150 mL of
citrated human plasma and 1 mg of enzymes diluted in 50 mL of
Milli-Q water. The reactionwas monitored for 30 min and 37 C by
the absorbance at 405 nm using the program Gen5 Data Analysis
(Biotek). Absorbance values for the control of plasma in absence of
the enzymes were subtracted from the results obtained for each
minute of reaction. In order to determine the inﬂuence of serine
protease inhibitors on the coagulant activity, the enzymes were
preincubated with 5 mM PMSF, leupeptin or benzamidine for
30 min at 37 C before initiating the kinetic assay.
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Fig. 2. (A) B. pirajai serine proteases after deglycosylation assays analyzed by 12%
SDS-PAGE under denaturing conditions. The reactions were performed by incu-
bating each enzyme (40 mg) with PNGase F (200 U) or neuraminidase (150 U)
at 37 C for 24 h. Lanes: 1- BpirSP41; 2- BpirSP41 þ PNGase F; 3- BpirSP41-
þ neuraminidase; 4- molecular mass standard; 5- BpirSP27; 6- BpirSP27 þ PNGase
F; 7- BpirSP27 þ neuraminidase. The bands related to the enzymes PNGase F
(w36 kDa) and neuraminidase (w43 kDa) are indicated in the gel. (B) Isoelectric
focusing of B. pirajai serine proteases in a 7% polyacrylamide gel. Samples: (1)
BpirSP27 (pI w4.7) and (2) BpirSP41 (pI w3.7).
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The assays on washed platelets were performed based on
previously described methodologies [25,26], using a dual Whole
Blood Lumi-Aggregometer (model 490 2D, Chrono-Log Corpora-
tion) and the software AggroLink.
2.15. Statistical analysis
The experiments were performed in triplicate and the results
were expressed as mean values  standard deviations (SD). The
statistical signiﬁcance of results was evaluated using Student’s t test
or analysis of variance (ANOVA) followed by Tukey test, considering
p values <0.05 as signiﬁcant.
3. Results
The fractionation of B. pirajai crude venom, performed by three
consecutive chromatographic steps, resulted in two adequately
separated serine proteases (Fig. 1). Yield calculations for this
isolation procedure indicated a low amount of both enzymes in the
venom of B. pirajai, each representing approximately 0.5% of the
total crude venom mass.
The two serine proteases presented molecular masses of
approximately 32 and 49 kDa when estimated by SDS-PAGE
(results not shown), and 27,121 and 40,639 Da when determined
by MALDI-TOF MS (results not shown). Considering that the MS
technique is more accurate than the SDS-PAGE, the results deter-
mined by MS should better reﬂect the actual molecular masses of
both enzymes, and thus the serine proteases were denominated
BpirSP27 and BpirSP41, respectively.
Deglycosylation with PNGase F showed that the enzymes
possess different levels of N-glycans in their structures. The
molecular mass of BpirSP27, estimated by SDS-PAGE, decreased
from 32 to 27 kDa (approximately 15%), while the reduction for
BpirSP41 was of 49e28 kDa (approximately 42%) (Fig. 2). On the
other hand, treatment with neuraminidase showed no visible
reduction in the molecular masses by SDS-PAGE of either enzyme0 10 20 30 40
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them (Fig. 3). An identity of 57% was observed according to the
number of fully conserved amino acids (*) presented when the two
N-terminal sequences were aligned, also showing several conser-
vative amino acid substitutions (: or .). These amino acid variations
show that the differences between the two enzymes stand beyond
the amounts of N-linked carbohydrates, possibly also reﬂecting in
structural and functional differences. Considering the variances
found in the N-terminal sequences, separate multiple alignments
were made for each of the enzymes, comparing them with other
SVSPs (Fig. 3).
The activities of BpirSP27 and BpirSP41 on TAME were signiﬁ-
cantly reduced in the presence of speciﬁc serine protease inhibitors
(PMSF, benzamidine, leupeptin and aprotinin), while the metal-
loprotease inhibitors EDTA, EGTA and 1,10-phenanthroline were
not able to promote signiﬁcant changes in the activities (Fig. 4).
Despite the pretreatment with the denaturing agents b-mercap-
toethanol and DTT resulted in some decrease in the activities of
both enzymes, only the value for BpirSP27 treated with DTT
showed to be signiﬁcantly different (p < 0.05) from the control of
enzyme in the absence of inhibitors (Fig. 4).
The results for pH variations showed that, overall, the enzymatic
activities of the serine proteases are higher at pH values ranging
from 6.0 to 10.5, with signiﬁcantly lower results only at more acidic
pHs (Fig. 5). The activities of both enzymes were also rather stable
after incubation at temperatures ranging from 4 to 60 C, with
signiﬁcant reduction merely after exposure to the extreme
temperature of 100 C (Fig. 6). In addition, both serine proteases in
aqueous solutions showed to be resistant to repeated cycles of
freezing (20 C) and thawing for use in the experiments (results
not shown).
B. pirajai serine proteases showed distinct proteolytic activities
on bovine ﬁbrinogen (Fig. 7). BpirSP27 seems to preferentially
degrade the Bb chain, with minor effects on the Aa chain (Fig. 7A),Fig. 3. Comparative analysis of the N-terminal amino acid sequences of BpirSP27 and Bpir
amino acid residues are part of disulﬁde bonds (yellow) or the catalytic site (red). NCBI GI n
82242792, 82244345, 82094948, 338855338, 32469800, 13959657, BpirSP41, 82244284, 11
13959657. (For interpretation of the references to color in this ﬁgure legend, the reader iswhile BpirSP41 promoted almost complete degradations of both Aa
and Bb chains at doses of 8 and 16 mg (Fig. 7B). None of the enzymes
were able to degrade the g chain of ﬁbrinogen. The ﬁbrinogenolytic
activity of BpirSP27 was completely abolished after preincubation
with PMSF and benzamidine (Fig. 7A), but BpirSP41 showed
a minor degree of inhibition by PMSF, which was evidenced by the
degradation of the Aa chain (Fig. 7B).
The results for the ﬁbrinolytic activity showed that BpirSP41
presented a higher ability to degrade the ﬁbrin clot than BpirSP27
(Fig. 8), also acting to greater extents on blood clots formed in vitro
(results not shown). This activity showed to be dependent on the
dose and the reaction time, since no visible halos of lysis were
noted after 24 h of incubation, differently fromwhat was observed
for the positive control of B. pirajai crude venom. These results may
indicate either a lower activity of these serine proteases on ﬁbrin
clots or the necessity of a longer reaction period for the occurrence
of degradation, which seems to be more probable since the results
after 48 h of incubation were very prominent, particularly for
BpirSP41 (Fig. 8).
Both serine proteases hydrolyzed the chromogenic substrate S-
2238 in a concentration-dependent manner, with slightly higher
values for BpirSP41 (Fig. 9A). After preincubation with PMSF and
benzamidine, a signiﬁcant reduction on the hydrolysis of S-2238
could be noted, whereas with EDTA the same effect was not
observed (Fig. 9B). Regarding metal ions, Cu2þ almost completely
inhibited the activity of both enzymes, and the activity of BpirSP27
also signiﬁcantly decreased in the presence of Mn2þ, while Ba2þ
and Ca2þ did not cause signiﬁcant effects on the hydrolysis of S-
2238 promoted by the enzymes (Fig. 9B). Other chromogenic
substrates as S-2222, S-2266 and S-2302 were also hydrolyzed by
B. pirajai serine proteases (Fig. 10A, B and C), but only BpirSP27 was
able to hydrolyze the substrate S-2251 for plasmin (Fig. 10D).
The evaluation of B. pirajai serine proteases regarding their
coagulant activities showed a decrease in the clotting time ofSP41 with each other and with other snake venom serine proteases. The highlighted
umbers (respectively, from top to bottom): BpirSP27, 82233395, 321172845, 13959617,
4837, 14285806, 123895619, 82233396, 82173559, 82248129, 461512, 82239726 and
referred to the web version of this article.)
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(Fig. 11). BpirSP41 presented higher coagulant potential (DCM
w3.5 mg) compared to BpirSP27 (MCD w20 mg) (Fig. 11), which is
also evidenced by the coagulation kinetics promoted by both
enzymes (Fig. 12A). Benzamidine and leupeptin almost completely
inhibited the coagulant activities of B. pirajai serine proteases,
while the inhibition promoted by PMSF showed to be less effective
especially against BpirSP41 activity (Fig. 12B and C). These data0
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Regarding their effects on washed platelets, both enzymes were
capable of promoting platelet aggregation in the presence or
absence of Ca2þ ion, even though BpirSP27 showed higher potential
compared to BpirSP41 (Fig. 13). While BpirSP27 induced a concen-
tration-dependent aggregation, with slightly higher values in the
presence of calcium, the aggregation induced by BpirSP410
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the presence of calcium (Fig. 13).
4. Discussion
4.1. Serine protease isoforms
It is well known that the presence of enzyme isoforms is
rather common in snake venoms, and some studies show the
isolation of serine protease isoforms from different snake
venoms, similarly to the present work with B. pirajai serine
proteases. Regarding Bothrops venoms, Serrano and colleagues
[27] isolated two acidic isoforms of serine proteases (KN-BJ1 and
KN-BJ2) from Bothrops jararaca venom, with molecular masses
around 38 and 39 kDa and similar N-terminal sequences. From1        2   3        4   5        6       7     8       9
A
Aα
Bβ
γ
Fig. 7. Fibrinogenolytic activity of B. pirajai serine proteases. Each enzyme at different doses
12% SDS-PAGE under denaturing conditions. The activity in the presence of inhibitors was
37 C. Samples: (A) BpirSP27 and (B) BpirSP41. Lanes: 1- ﬁbrinogen control (80 mg); 2- ﬁbrin
ﬁbrinogen þ BpirSP (8 mg); 6- ﬁbrinogen þ BpirSP (16 mg); 7- ﬁbrinogen þ BpirSP (8 mg) þthat same venom, Serrano and coworkers [28] obtained three
different isoforms of the serine protease TL-BJ with similar
amidolytic and coagulant activities, and slight differences in their
molecular masses by SDS-PAGE (30, 31 and 32 kDa), N-glyco-
sylation levels and N-terminal sequences. Serrano and coworkers
[29] also isolated two basic serine proteases (MSP1 and 2) from
the venom of Bothrops moojeni with molecular masses of 34 and
38 kDa and different effects on platelets and TAME. Petretski and
colleagues [30] isolated two isoforms of a thrombin-like enzyme
from Bothrops atrox venom that showed the same enzymatic
activities and N-terminal sequences, but with small differences in
their molecular masses.
Reports of isoforms are more often related to studies of tran-
scriptome or proteome. Saguchi and coworkers [31], for example,
described the sequencing of several clones of serine proteases fromB
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was incubated with bovine ﬁbrinogen at 37 C for 2 h and the activity was evaluated by
assessed after preincubation of the enzymes with PMSF or benzamidine for 30 min at
ogen þ BpirSP (1 mg); 3- ﬁbrinogen þ BpirSP (2 mg) 4- ﬁbrinogen þ BpirSP (4 mg); 5-
PMSF (5 mM); 8- ﬁbrinogen þ BpirSP (8 mg) þ benzamidine (5 mM); 9- BpirSP (4 mg).
0,0
0,2
0,4
0,6
0,8
1,0
1,2
1,4
1,6
1,8
2,0
2,2
2,4
2,6
* *
*
*
*
*
*
*
2    4    8   16   32
Fi
br
in
ol
yt
ic 
ac
tiv
ity
 4
8h
 (c
m)
2    4   8   16   32
BpirSP27 (μg)B. p
iraja
i
(40
 μg)
PB
S
BpirSP41 (μg)
*
Fig. 8. Fibrinolytic activity of B. pirajai serine proteases. The activity was assessed by
measuring the halos of lysis (in cm) formed after incubation of ﬁbrin plates with
different doses of BpirSP27 and BpirSP41 at 37 C for 48 h. Results expressed as
means  SD (n ¼ 3). (*) Values signiﬁcantly different from the negative control (PBS)
(p < 0.05).
D.L. Menaldo et al. / Biochimie 94 (2012) 2545e25582552the cDNA library of B. jararaca venom gland. Ohler and coworkers
[32] showed that the proteome of Bothrops alternatus venom pre-
sented a wide range of acidic serine proteases with high homology
to others from different snake species.0 5 10 15 20 25 30 35 40
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Fig. 9. (A) Effects of B. pirajai serine proteases on the chromogenic substrate S-2238 (for
determined by the absorbance at 405 nm after 10 min of reaction at 37 C with different co
metal ions and inhibitors on the S-2238 hydrolytic activity of B. pirajai serine proteases. Each
inhibitors (5 mM) and then the reaction was initiated by adding the substrate. Results are
signiﬁcantly different from the control of activity (considered as 100%) (p < 0.05).According to the analysis of the genomic DNA from Trimeresurus
ﬂavoviridis, venom gland genes encoding serine proteases form
amultigene family, probably emerging by duplication and variation
of a single ancestral gene [33]. It is known that snakes possess
different genes that encode various isoforms of several enzymes,
but the expression and synthesis of these different isoforms are not
yet well understood. It is also known that small alterations among
the amino acid sequences of serine protease isoforms may cause
great differences in their enzymatic activities [7,31].4.2. Glycosylation and other biochemical features
Similarly to BpirSP27 and BpirSP41, most of the SVSPs already
described are acidic single polypeptide chain glycoproteins with
variable molecular masses due to differences in their carbohydrate
content [7]. From Bothrops jararacussu venom, for example, are the
enzymes FC-Bj withMr greater than 50,000,19% carbohydrates and
pI 3.3e4.4 [34]; jararacussin-I with Mr of 28,000 and pI 5.0 [35]; DV
withmolecular mass of 37.5 kDa and pI 5.2 [36] and BjussuSP-I with
molecular mass around 61 kDa and pI 3.8 [37]. Other acidic serine
proteases from Bothrops snake venoms include BaIII-4 from B. atrox
venom, with molecular mass of 33 kDa and pI 5.0 [38], and BpSP-I
from Bothrops pauloensis venom, with molecular mass of 34 kDa
and pI 6.4 [39]. Neutral and basic SVSPs are also described in the
literature, including the enzymes MOO3 from B. moojeni venom,
with pI 7.8 [40], jararassin-I, with pI 7.4e7.8 [41], and PA-BJ, with pI
greater than 9.0 [42], both from B. jararaca venom.
Most SVSPs contain varying numbers of glycosylation sites
linked to asparagine in non-homologous regions of their amino
acid sequences and thus, the rate of glycosylation differs greatly
among these enzymes [13,43]. Studies of glycosylation of BPA from
B. jararaca venom, for example, showed that approximately 62% of
its high molecular mass (67 kDa) is due to its carbohydrate content
[44]. Also from B. jararaca venom, the three serine protease0
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D.L. Menaldo et al. / Biochimie 94 (2012) 2545e2558 2553isoforms TL-BJ 1, 2 and 3 differed in the N-glycosylation rates, with
two of the enzymes having their molecular masses of 30 and 31 kDa
reduced to 23 kDa after treatmentwith PNGase F, whereas themass
of the third isoform (32 kDa) remained unaltered [28]. From the
venom of B. jararacussu, while some serine proteases presented
glycosylation rates around 5% of their molecular masses [35,36],
others showed much higher carbohydrate contents, as the enzyme
FC-Bj with 19% carbohydrates [34], BJ-48 with 42% of its molecular
mass of 52 kDa corresponding to N-linked carbohydrates, including
12.8% sialic acid residues [45], and BjussuSP-I, which had its
molecular mass of 61 kDa reduced to 37 and 45 kDa after degly-
cosylation with PNGase F and neuraminidase, respectively [37].
Similarly, the enzyme TLBan from Bothrops andianus venom had its
molecular mass of 29 kDa decreased to 25 and 22 kDa after treat-
ment with neuraminidase and PNGase F, respectively [46].
Deglycosylation with PNGase F is promoted by the hydrolysis
of bonds between residues of asparagine and oligosaccharides(N-glycans) [47]. Considering the reduction in the molecular
masses of both B. pirajai serine proteases, it’s clearly noticed that
BpirSP41 presents higher levels of N-linked oligosaccharides than
BpirSP27. Furthermore, treatment with the enzyme neuraminidase
showed that these serine proteases do not contain signiﬁcant
amounts of sialic acid molecules linked to their structures. It’s
important to notice that SVSPs may also present O-glycosylation
sites [7,48], and thus, BpirSP27 and BpirSP41 may present greater
carbohydrate content than that determined only by treatment with
PNGase F.
The importance of carbohydrates in the structureefunction
relationship of serine proteases is not entirely understood. In
many cases, including those of BjussuSP-I [49] and BpSP-I [39], it
was shown that the N-glycosylation interferes with the
catalytic activity of the enzymes. In fact, the presence of these
glycosylation sites near the catalytic triad of serine proteases is
usually described as a possible factor inﬂuencing their enzymatic
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D.L. Menaldo et al. / Biochimie 94 (2012) 2545e25582554activities [48]. In accordance, Zhu and coworkers [50] showed that
the difference between the catalytic efﬁciency of two serine
proteases from Agkistrodon acutus venom was related to the pres-
ence of different glycans near the active site of these enzymes. On
the other hand, there are also reports that convey that carbohy-
drates are more important for the stabilization of serine proteases
than for their catalytic activity [51].0 5 10 15 20 25 30
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a cDNA clone from the venom gland of B. jararaca, sequenced by
Saguchi and coworkers [31]. Interestingly, this enzyme exhibited
higher sequence identity to those of serine proteases from other
snake genera, including Crotalus, Trimeresurus, Gloydius and
Agkistrodon. On the other hand, BpirSP41 showed higher identity to
the N-terminal sequences of other Bothrops serine proteases,
including those from B. jararacussu, B. alternatus, B. atrox, B. jararaca
and Bothrops insularis, with 100% identity to the serine protease
from that latter species.
The high homology among SVSPs can be observed by the pres-
ence of several conserved amino acid residues [52]. The comparison
of the amino acid sequences of snake venom thrombin-like
enzymes with those of classical serine proteases such as chymo-
trypsin, trypsin, thrombin and kallikrein shows different levels of
identity, displaying, in general, moderate sequence homology and
several substitutions. Among the conserved regions are the cata-
lytic triad formed by the amino acid residues His57, Asp102 and
Ser195, the substrate recognition sites S1 (Asp189) and S2 (Gly216),
and twelve cysteine residues forming six disulﬁde bonds (usually
between pairs 22e157, 42e58, 91e250, 136e201, 168e182 and
191e220) (chymotrypsinogen numbering) [52]. Without the
complete amino acid sequences of BpirSP27 and BpirSP41 it’s not
possible to verify if all these amino acid residues described as
important for the activities of this class of enzymes are in fact
conserved in their sequences, but at least part of them, including
three highly conserved cysteine residues (corresponding to posi-
tions 7, 26 and 42) and the histidine residue of the active site
(position 41) are presented in the 50 ﬁrst amino acid residues of
their N-terminal sequences.
4.4. Enzymatic properties and stability
B. pirajai serine proteases proved to be rather stable at
different pH values and temperatures, and BpirSP41 was appar-
ently less affected by these variations than BpirSP27. These
results are consistent with several studies showing that serine
proteases are usually resistant to inactivation by extremetemperatures and pH values, on the contrary to what is observed
for metalloproteases [53].
SVSPs are typically very stablemolecules, in large part due to the
presence of six disulﬁde bonds in most of them [13], but this
stability is also usually attributed to carbohydrates covalently
bound to their structures [54,55], which could explain the higher
stability of BpirSP41 compared to BpirSP27. Lee and colleagues [56]
showed that brevinase from Agkistrodon blomhofﬁi brevicaudus
venom lost its thermostability after deglycosylation, and Silva-
Junior and coworkers [45] obtained similar results for BJ-48 from
B. jararacussu venom. Additionally, the decrease in the activities of
BpirSP27 and BpirSP41 after pretreatment with the denaturing
agents b-mercaptoethanol and DTT suggests the importance of
disulﬁde bonds in the stabilization of the native structures of these
enzymes, reﬂecting in the conservation of their activities. Studies
show that the denaturation promoted by these agents commonly
affect the biological activities of SVSPs [52], as described for ﬂa-
voviridiobin from T. ﬂavoviridis [57] and for leucurobin from
Bothrops leucurus venom [58].
Although BpirSP41 showed to be susceptible to the reversible
inhibitors benzamidine and leupeptin, results indicated that this
isoform was less sensitive to PMSF than BpirSP27. Considering the
differences between B. pirajai serine proteases described so far, it’s
possible that the higher content of N-glycans may be related to
a greater degree of protection of the serine residue in the active site
of BpirSP41, resulting in lesser inhibition by PMSF. In fact, some
studies suggest that N-glycans could be involved in blocking the
access of inhibitors to the active site of enzymes [48], as described
for the deglycosylated form of BJ-48, whichwasmore susceptible to
inhibition by aprotinin than its native form [45].
Several studies showed that the inhibitory effects of speciﬁc
serine protease inhibitors can vary greatly from one enzyme to
another. Cho and coworkers [59] showed that the proteolytic
activity of calobin II was almost completely inhibited by PMSF,
while inhibitors such as aprotinin and benzamidine reduced only
about 20% of its enzymatic activity. Contrarily, Vieira and coworkers
[41] showed that the coagulant activity of jararassin-I was inhibited
to a greater extent by benzamidine than by PMSF.
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reduced by Cu2þ ion and BpirSP27 was also inﬂuenced by Mn2þ.
Even though Cu2þ markedly inhibited the activities of B. pirajai
serine proteases and BpSP-I [39], the same effect was not observed
for the enzymes brevinase [56] and ABUSV-SPase [60]. Moreover,
Mn2þ decreased the activity of BpirSP27 and BjussuSP-I [37],
increased the activity of ABUSV-SPase [60] and did not cause
signiﬁcant effects on the activities of BpirSP41, BpSP-I [39] and
brevinase [56]. Thus, these discrepancies may be related to struc-
tural differences between these enzymes, which could reﬂect in
different degrees of sensitivity to ions, though more detailed
structural studies are needed to evaluate this theory. Liu and
colleagues [60] suggested that the different ions could promote
small changes in the conformation of proteins depending on their
speciﬁc chemical characteristics, resulting in different effects on the
activities of these enzymes.
Despite these results regarding metal ions and differently from
what is observed formetalloproteases, which are dependent on Zn2þ
[43], serine proteases are not described as dependent on any ion. In
fact, the metal chelators EDTA, EGTA and 1,10-phenanthroline,
commonly used as metalloprotease inhibitors, were not able to
promote signiﬁcant reduction in the activities of BpirSP27 and
BpirSP41. Although not usual, there are also reports of serine
protease activities that were reduced in the presence of chelating
inhibitors such as EDTA [29,40,46,61] and 1,10-phenanthroline [37].
4.5. Functional activities
SVSPs are not considered lethal by themselves and their toxicity
is mainly related to their effects on the hemostatic system [6]. In
fact, many SVSPs are classiﬁed as thrombin-like enzymes, consid-
ering their ability to degrade ﬁbrinogen and promote coagulation
[6,13]. Although the majority of SVSPs induce coagulation, there are
also those which are unable to do so, as PA-BJ [42], and those which
degrade ﬁbrinogen but do not cause coagulation, as BPA [62].
In most cases, thrombin-like enzymes act only on the Aa chain
of ﬁbrinogen, as batroxobin from B. atrox [63], KN-BJ and
bothrombin from B. jararaca [27,64], bhalternin from B. alternatus
[65] and BjussuSP-I from B. jararacussu venom [37], but there are
also those serine proteases that act preferably on the Bb chain of
ﬁbrinogen, as BpirSP27, including contortrixobin from Agkistrodon
contortrix contortrix [66], stejneﬁbrase 2 from Trimeresurus stejne-
geri [67], jararassin-I from B. jararaca [41] and BJ-48 from
B. jararacussu venom [45]. Similarly to thrombin, some SVSPs can
also act on both Aa and Bb chains, as BpirSP41, and those include
FC-Bj and jararacussin-I from B. jararacussu [34,35], MOO-3 from
B. moojeni [40] and brevinase from Agkistrodon blomhofﬁi brevi-
caudus venom [56].
The speciﬁc cleavage of ﬁbrinogen promoted by B. pirajai serine
proteases must be at least partially related to their ability to
coagulate the human plasma. MCD and coagulation kinetics results
indicated that BpirSP41 presents higher coagulant potential than
BpirSP27, which could be related to their different actions on
ﬁbrinogen, with BpirSP27 degrading only the Bb chain while
BpirSP41 acted on both Aa and Bb chains. Other potent coagulant
enzymes were already described from Bothrops snake venoms,
including a thrombin-like serine protease from Bothrops asper
venom, with a MCD of approximately 4.1 mg [68], close to that
obtained for BpirSP41, and BpSP-I from B. pauloensis venom, with
a MCD of approximately 1.3 mg [39].
Besides acting on ﬁbrinogen, it’s possible that BpirSP27 and
BpirSP41 promote plasma coagulation by acting on other factors of
the coagulation cascade, as assayed using different chromogenic
substrates. Although the results suggested that both serine prote-
ases act on different components of the coagulation cascade, thesedata may not reﬂect the actual effects that occur in vivo, since these
reactions in the organism are subjected to several conditions not
presented in in vitro tests. Thus, although both BpirSP27 and
BpirSP41 hydrolyzed speciﬁc substrates for glandular and plasma
kallikrein (S-2266 and S-2302, respectively), for example, these
enzymes should not be classiﬁed as kallikrein-like unless their
ability to release kinin from plasma kininogen was evaluated.
According to Magalhães and coworkers [58], the serine protease
leucurobin isolated from B. leucurus venom showed high proteo-
lytic activity on the substrates S-2302 and S-2266 but did not
present kallikrein-like activity, not releasing kinin from bovine
plasma. Additionally, as only BpirSP27 presented proteolytic
activity on the substrate S-2251 for plasmin, one could expect that
this enzymewould exhibit greater action on the ﬁbrinolytic system
than BpirSP41, which did not occur according to the experimental
model of ﬁbrinolysis used in the present work.
In the same way many SVSPs act on ﬁbrinogen and other
coagulation factors, some are also capable of acting on the process
of ﬁbrinolysis, degrading the ﬁbrin clot directly, as BpirSP27 and
BpirSP41, or indirectly by the formation of plasmin [69e71]. Studies
indicate that, despite several SVSPs present activity on both
ﬁbrinogen and ﬁbrin, some are simply not ﬁbrinolytic [1]. Sant’Ana
and colleagues [37], for example, showed that BjussuSP-I presented
a dose and time-dependent ﬁbrinolytic activity. In contrast, other
serine proteases from Bothrops venoms, as BPA [62] and BpSP-I [39],
were not able to degrade ﬁbrin clots.
Platelet aggregation is a phenomenon dependent on calcium,
since this ion is important for the activation and secretion of
platelets [72] and also for maintaining the structure of the heter-
odimeric complex GPIIb/IIIa [73]. The fact that B. pirajai serine
proteases induced aggregation in the absence of calcium shows
that their aggregation mechanisms are Ca2þ-independent. Addi-
tionally, since the activity induced by BpirSP27 was higher in the
presence of calcium, it could indicate that this enzyme may be
related to the inﬂux of this ion in platelets, leading to an intracel-
lular signaling that culminates in the secretion of platelet granules
and in the ampliﬁcation of aggregation [72].
Several SVSPs are able to promote platelet aggregation in
different ways. Some activate platelets similarly to thrombin,
independently of the presence of ﬁbrinogen, as PA-BJ from
B. jararaca [42] and MSP1 and thrombocytin from B. moojeni
[29,74]. Other enzymes, as bothrombin from B. jararaca [64] and
cerastotin from Cerastes cerastes venom [75], were able to aggregate
washed platelets only in the presence of exogenous ﬁbrinogen.
There are also some serine proteases that did not induce or inhibit
platelet aggregation, as BjussuSP-I from B. jararacussu [49] and
jerdoﬁbrase from Trimeresurus jerdonii [76].
5. Concluding remarks
The present work successfully isolated and characterized two
serine proteases from the venom of B. pirajai, a threatened snake
species whose venom is only partially characterized to date. Both
enzymes presented distinct and remarkable effects on hemostasis,
degrading ﬁbrinogen, ﬁbrin clots, promoting coagulation and
platelet aggregation, also probably acting on other factors of the
coagulation cascade. The results suggested that the differences
between the activities of these enzymes should bemainly related to
their pronounced structural differences, including different amino
acid sequences and N-glycosylation rates. These N-linked carbo-
hydrates seem to play an important role in the stability presented
by these serine proteases, possibly also inﬂuencing their catalytic
activities.
Studies on snake venom proteins may result in the direct use of
these enzymes or of part of their structures as models for the
D.L. Menaldo et al. / Biochimie 94 (2012) 2545e2558 2557development of new drugs. Thus, the biochemical and structural
characterization of SVSPs as well as the understanding of their
mechanisms of action in inducing toxic and pharmacological effects
are very important to allow the possible use of these enzymes in
several medical areas. Regarding BpirSP27 and BpirSP41, the next
steps of this study include further structural and functional char-
acterization, with the evaluation of their effects on the human
complement system and their contribution to the inﬂammatory
response promoted by B. pirajai snake venom.
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